LY 2784544
- ₹13466.3 - ₹54222.43
- Product name: LY 2784544
- CAS: 1229236-86-5
- MF: C23H25ClFN7O
- MW: 469.94
- EINECS:-0
- MDL Number:MFCD20482143
- Synonyms:LY2784544(gandotinib);3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[;3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine;LY 2784544;3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine;3-(4-chloro-2-fluorobenzyl)-2-Methyl-N-(3-Methyl-1H-pyrazol-5-yl)-8-(MorpholinoMethyl)iMidazo[1,2-b]pyridazin-6-aMine;LY2784544/LY-2784544;IMidazo[1,2-b]pyridazin-6-aMine, 3-[(4-chloro-2-fluorophenyl)Methyl]-2-Methyl-N-(5-Methyl-1H-pyrazol-3-yl)-8-(4-MorpholinylMethyl)-
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML2567
- Product descriptionLY2784544 ≥98% (HPLC)
- Packaging5MG
- Price₹13466.3
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML2567
- Product descriptionLY2784544 ≥98% (HPLC)
- Packaging25MG
- Price₹54222.43
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML2567 | LY2784544 ≥98% (HPLC) | 5MG | ₹13466.3 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML2567 | LY2784544 ≥98% (HPLC) | 25MG | ₹54222.43 | 2022-06-14 | Buy |
Properties
Density :1.45
storage temp. :Store at -20°C
solubility :≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic
form :solid
pka :14.12±0.10(Predicted)
color :Light yellow to yellow
storage temp. :Store at -20°C
solubility :≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic
form :solid
pka :14.12±0.10(Predicted)
color :Light yellow to yellow
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
LY2784544 is a potent, ATP-competitive inhibitor of janus kinase 2 (JAK2) that less effectively inhibits JAK3 (IC50s = 3 and 48 nM, respectively). It also inhibits JAK2 containing the V617F mutation (IC50 = 20 nM), blocking STAT5 phosphorylation and proliferation of Ba/F3 pro-B-cells expressing this constitutively active JAK2 mutant form. When given by oral gavage, LY2784544 significantly reduces the growth of Ba/F3 pro-B-cells in SCID mice without affecting erythroid progenitors, reticulocytes, or platelets. JAK inhibitors, including LY2784544, may be useful in hematological malignancies.More related product prices
LY 2606368 936091-26-8 Momelotinib PD 0325901 Tozasertib 1268524-70-4 PACRITINIB LY-364947 LY2409881 trihydrochloride LY3214996 2-(4-((4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol Etalocib LY2228820 LY-2562175 LY 294002 HYDROCHLORIDE LY2828360Related product price
- PD 0325901
₹15891.1-60457.63 - Tozasertib
₹7836.6 - 1268524-70-4
₹21390.2-75894.08